Activation of the Immune System by TNFerade

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43CA105733-01
Agency Tracking Number: CA105733
Amount: $99,544.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solitcitation Year: 2004
Solitcitation Topic Code: N/A
Solitcitation Number: PHS2004-2
Small Business Information
GENVEC, INC.
GENVEC, INC., 65 W WATKINS MILL RD, GAITHERSBURG, MD, 20878
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 CHARLES King
 (240) 632-5537
 rking@genvec.com
Business Contact
Phone: (240) 632-5537
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): This proposal will investigate the mechanism of action of TNFerade, a promising cancer treatment now in clinical testing. In TNFerade, the TNF coding sequence is controlled by a radiation responsive promoter, egr-1, is

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government